Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brett K. Haumann currently holds 242,499 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brett K. Haumann has been a net seller of TBPH stock. They have purchased $0 and sold $1.3M worth of shares.
Brett K. Haumann's most recent insider trade was on Feb 20, 2021, when they sold 35,672 shares at $18.79 per share.
Brett K. Haumann serves as Executive at Theravance Biopharma, Inc. (TBPH). They have executed 38 insider transactions totaling $1.3M over their tenure at the company.
Brett K. Haumann holds the position of Executive at Theravance Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Brett K. Haumann has shown a selling trading pattern, with $0 in total purchases and $1.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brett K. Haumann was on Feb 20, 2020, when they sold $870.4K worth of TBPH shares. This transaction involved 33,608 shares at $25.90 per share.
Brett K. Haumann currently owns 242,499 shares of Theravance Biopharma, Inc. (TBPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brett K. Haumann's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brett K. Haumann has 38 Form 4 filings on record as an insider at Theravance Biopharma, Inc..
Set alerts for Brett K. Haumann and 40,000+ other insiders.